Thursday, 22 May 2014

Global Healthcare Business Intelligence Market - Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

During the forecast period healthcare providers overtake healthcare payers significantly in terms of growth in the market. Conventional business intelligence leads the global healthcare business intelligence market, by technology, when it comes to revenue. Although mobile business intelligence or cloud business intelligence pose a huge market growth potential due to rising usage of mobile by the healthcare society, and growing demand of health systems and hospitals for a more cheaper, accessible, flexible, scalable and agile form of business intelligence in this expenditure constraint healthcare environment. 

Rising demand for decline in healthcare costs coupled with federal healthcare mandates enhancing the usage of business intelligence solutions are some of the factors which are expected o drive the market. Even though, the market is expected to grow there are some factors restraining the growth such as lack of cross-functional skilled resources, complexity of it systems and lack of flexibility. 


The global healthcare business intelligence market is mainly segmented by function, technology, application and end user. On the basis function the healthcare business intelligence market can be segmented into query and reporting tools, online analytical processing (OLAP) and visualization tools and performance monitoring/management and alerts. Furthermore, when is market is segmented on the basis of technology it includes traditional business intelligence, mobile business intelligence and cloud business intelligence. 
On the basis application the healthcare business intelligence market can be segmented into clinical care optimization (quality and safety), physician performance monitoring and benchmarking, financial analysis, regulatory compliance and reporting and operational performance and cost management. The financial analysis is further sub-segmented into claims analysis and revenue cycle. On a similar note, the operational performance and cost management is sub-segmented into service line analysis and supply chain management, human and resource capital management, marketing analysis. Lastly the market is segmented on the basis of end user into payers, hospitals, providers, physician practices, IDN, ACO, MCO and HIE.  

Mobile BI and cloud BI is expected to record highest growth among the healthcare business intelligence market in the forecast period. Their constructive growth is endorsed to the growing swing of healthcare organizations towards cloud computing representation and increasing usage of Smartphone by the medical society. Clinical application is expected to be the major driver for the market growth in the forecasted period. Among all functions, online analytical processing (OLAP) and visualization tools market is expected to have an edge over reporting and monitoring tools. 

Based on geography, North America, especially the U.S. dominates the market and is also expected to grow at the highest CAGR during the forecast period. Asia Pacific is emerging to be an opportunistic market with growing adoption of healthcare and information Technology (HCIT), and consequently business intelligence tools. In Japanese market a variety of encouraging government initiatives are designed and developed. These new IT reform strategy, e-Japan policy and iJApan Strategy 2015 are some of the government initiatives which are focusing on escalation of healthcare service.

Leading players of the healthcare business intelligence market are Information Builders, IBM Corporation, MicroStrategy, Microsoft Corporation, Oracle Corporation, SAP AG, Qlik Technologies, Inc., SAS Institute, Inc., Tableau Software , TIBCO Software Inc., and other players such as CitiusTech, Accenture, Computer Sciences Corporation, Jaspersoft, Dimensional Insight, Klipfolio Inc., Agilum Healthcare Intelligence, Perficient, Inc., Siemens Healthcare, , Infosys, Tata Consultancy Services, Hexaware Technologies Limited and Wipro Limited among others.


This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
·     It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments.


About Us:-
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us:
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Browse Market Research Report:-

.

Wednesday, 21 May 2014

Autism Spectrum Disorder Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2013 - 2019

Pharmaceuticals copy
Autism spectrum disorder (ASD) is a group of multifaceted neurodevelopment disabilities characterized by social, behavioral and communication challenges. This condition is characterized by communication difficulties, social impairment and repetitive and stereotyped behavioral patterns. It is a spectrum condition because while all people affected with autism share some similar difficulties, the level of medical condition affects them in different ways. Symptoms of ASD vary widely and it may sometimes go unrecognized especially in mildly affected children. Early indicators include loss of language or social skills, lack of response, poor eye contact, no single words or two-word phrases by the age of 2 years. If left unrecognized by the age of 3 years, one may recognize later through impaired ability to make friends, stereotyped or unusual use of language, inability to initiate or withstand a conversation with others; varying specific routines or rituals and impairment or absence of imaginative and social interactions.
Presently, there are no medications that can treat ASD or its core symptoms. It is an underserved market with only two FDA approved drugs Abilify (aripiprazole) and risperidone. These drugs belong to the anti-psychotics therapeutic class, but are approved for the treatment of irritability associated with autistic disorder. Besides, certain other classes of drugs such as antidepressants, anticonvulsants and stimulants are prescribed off-label for reducing autism related neurological challenges.
Patent expiration of Abilify will lead to decline in the market growth which is expected to offset by new introductions which may improve the therapeutic benefits. The growth of this market is primarily attributed to the increasing prevalence of ASD. According to CDC, average prevalence of ASD in Asia, Europe and North America is 1%. Further, the estimates state that the prevalence rate has risen form 1 in 150 children in 2000 to 1 in 68 children in 2010.
Abilify is a product of Bristol-Myers Squibb and Otsuka Holdings Co., Ltd. While, risperidone is a generic market with many key players such as Janssen Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Actavis, Inc., Mylan Pharmaceuticals, Inc., Ranbaxy Laboratories Limited and Sun Pharmaceutical Industries Limited.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of 
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
About us
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Contact Us


Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.

Tuesday, 13 May 2014

Global Trial Management System Market Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2019

According to a new market report published by Transparency Market Research "Clinical Trial Management System Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019," the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019.

Browse Global Clinical Trial Management System Market Report with Full TOC at http://www.transparencymarketresearch.com/clinical-trial-management-systems-market.html

Globally, the CTMS market is witnessing significant growth due to increasing R&D investment in pharmaceutical, life science and clinical research industries. It empowers organizations and research centers to enhance productivity and effectiveness of clinical trials by advancing and managing clinical trials. Integration of CTMS with HIS provides more accurate and time saving documentation, and it is also one of the major driving factor for the growth of the CTMS market. Additionally, increasing prevalence of diseases is supporting clinical trials in different regions, and increased clinical research outsourcing is playing a major role in the growth of the CTMS market. Presence of various end users such as pharmaceuticals, clinical research organizations (CRO) and healthcare providers has increased the acceptance of CTMS. The global CTMS market was estimated to be USD 844 million in 2013. It is likely to grow at a CAGR of 14% during 2013 to 2019 to reach USD 1,848.5 million in 2019.

North America is a traditional clinical trial region. The average cost of pharmaceutical research and development for a successful drug continues to increase from pre-clinical to FDA approval. Clinical trials in the U.S. have been funded and sponsored by National Institute of Health (NIH), other government agencies, academic groups, voluntary health organizations and industry. According to the U.S. National Institute of Health (Clinical Trial government registry) in 2011, there were 56,981 clinical trials conducted in the U.S.

In Europe, countries in Central and Eastern Europe provide abundant chance to life science companies for clinical development. According to Oracle Corporation, a CTMS company, the percentage of clinical trials conducted in Western Europe has decreased from 25% to 19% and in Eastern Europe, the same has increased from 10% to 13% during 2006-2010.

However, Asia is the fastest growing region in the clinical trial management system market. Asia has become one of the fastest-growing markets for pharmaceutical products. Improved industry regulatory laws and patent expiration laws in various countries including Japan, China and India, have led to the expansion of the clinical trials market in Asia. Asia has lower cost of conducting clinical trials compared to Europe or the U.S.

Related & Recently Published Reports by Transparency Market Research 
The clinical trial management system market is segmented as follows:

Membrane Technology Market, By Delivery Mode 
  • Cloud based clinical trial management system
  • Web based clinical trial management system
  • On-premise clinical trial management system
Membrane Technology Market, By End user 
  • Pharmaceuticals
  • Clinical Research Organizations
  • Healthcare providers
Membrane Technology Market, By Type 
  • Enterprise based clinical trial management system
  • Site based clinical trial management system
Browse Global Clinical Trial Management System Market Report with Full TOC at http://www.transparencymarketresearch.com/clinical-trial-management-systems-market.html

Membrane Technology Market, By Components 
  • Software
  • Hardware
  • Services
Membrane Technology Market, by Geography 
  • North America
    • U.S.
  • Europe
    • Germany
    • France
    • U.K.
    • Russia
    • Poland
  • Asia
    • China
    • South Korea
    • Taiwan
    • India
  • Rest of the World (RoW)
Browse Medical Devices Market Research Reports with TOC @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html 

About Us 

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com/
Blog: http://www.tmrblog.com/

Monday, 12 May 2014

Human Reproductive Technologies Market - Global Industry Analysis, Size, Procedures, Growth, Trends and Forecast, 2013 – 2019

Human reproductive technologies are used to conceive pregnancy by means of artificial or partially artificial medical procedures. These technologies are primarily used in infertility treatments. Reproductive technologies involve collecting and storing sperm and eggs below 0°C for artificial insemination and in vitro fertilization.

Browse the full report with request TOC at
Currently, North America dominates the global human reproductive technologies market and is followed by Europe due to emerging of number of clinics specializing in aiding the reproductive procedures in these regions. Emerging economies of Asia-Pacific, Latin America and the Middle East are also expected to exhibit rapid growth in this market due to rapid adoption of technological advances in fertility treatments.

The major factors driving the human reproductive technology market include the rising demand and willingness to adopt new scientific technologies by people allowing infertile couples to create biologically-related children. However the concerns regarding financial and bioethical issues may pose a challenge to the market growth for human reproductive technologies.

Some of the key players contributing to the global human reproductive technologies market include Bayer AG, Berlex Laboratories, Inc., Bristol-Myers Squibb Co., Church & Dwight Company, Inc., Eli Lilly & Co., Endocare, Inc., GlaxoSmithKline PLC, Icos Corp., Novartis International AG, Organon international, Inc., Ortho-Mcneil Pharmaceutical, Inc., Pfizer, Inc., Princeton Biomeditech Corp., Serono S.A., Vivus, Inc. and Watson Pharmaceuticals, Inc.

Related Report:  

This research report analyzes this market depending on its market segments, major geographies, and current market trends.
Geographies analyzed under this research report include
  • North America 
  • Asia Pacific 
  • Europe 
  • Rest of the World
This report provides comprehensive analysis of
  • Market growth drivers 
  • Factors limiting market growth 
  • Current market trends 
  • Market structure 
  • Market projections for upcoming years
Technologies
  • Assisted reproductive technology 
  • Contraception 
  • Prognostics 
  • Others 
  • Application 
  • Therapeutics 
  • Diagnosis 
  • Devices 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.


 About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com/
Blog: http://www.tmrblog.com/

Browse Market Research News: http://www.transparencymarketresearch.com/press-releases.htm
Browse Market Research Articles: http://www.transparencymarketresearch.com/articles.htm

Thursday, 8 May 2014

Cystic Fibrosis Therapeutics Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2013 – 2019

Transparency Market Research Reports included a detailed market survey and analysis trends on “Cystic Fibrosis Therapeutics Market”. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure. Cystic fibrosis (CF), also known as mucoviscidosis, is autosomal recessive disorder that is characterized by abnormal transport of chloride and sodium across an epithelium. The occurrence of disease leads to thick and viscous secretions which causes a life threatening impact on the lungs, the pancreas, liver, and intestine, and also blocks the pancreatic enzymatic actions on the body. Cystic fibrosis is caused by mutation in gene, required for protein cystic fibrosis transmembrane conductance regulator (CFTR), a protein required for regulating sweat, mucus and body secretions. 


The market for CF therapeutics is segmented on the basis of therapeutic products such as Pulmozyme, TOBI, Kalydeco, Cayston, Aeroquin, Arikace and others. Further, the market is also segmented on the basis of geography, such as North America, Europe, Asia-Pacific and Rest of the World (RoW). The European market is considered as most lucrative market for CF Therapeutics, followed by the North American Market. However, Asia-Pacific is considered as the least important market, owing to least prevalence of the disorder.

The market for CF Therapeutics is projected to show a promising and lucrative growth in the next few years due to continued R&D activities in this field. At present, there are more than 30-40 drugs (including bronchodilators, antibiotics, NSAIDs, steroids and others) available in the market. Further owing to continued extensive research and development activities, a variety of medicines are expected to launch in the market in future period. Increasing global awareness for cystic fibrosis therapy, technological advancements in the R&D and increase in the prevalence of cystic fibrosis are some of the factors estimated as the major drivers for CF Therapeutics Market. However, complicated pathophysiology, high cost of treatment and R&D and increase in genetic mutation rate are some of the factors expected to hinder the growth of this market.

Some of the major players operating in this market includes Novartis International AG, ChiesiFarmaceuticiSpA, Vertex Pharmaceuticals, Genentech, Inc., and Gilead Sciences, Inc. amongst others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

Contact Us

Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030

Browse Market Research Report:-